News
(2)April 2026
Geron Nears FDA Decision on Cancer Drug Imetelstat
# 🔎 What This Document Is This is Geron Corporation's **Annual Report to Security Holders**. Think of it as the company's yearly "check-in" letter to its investors, going beyond the basic SEC forms to tell a more complete story of their business, progress, and plans. It’s designed to be a comprehe
Geron Sets Annual Meeting to Vote on Directors and Equity Plan
# 🧾 What This Document Is This is a **proxy statement** (DEF 14A), a formal document sent to shareholders before a company's annual meeting. Its purpose is to give you the information you need to vote on important company matters. Think of it as an agenda and a detailed guidebook for the meeting.
Peers in Biotechnology
Vertex Pharmaceuticals Incorporated
Regeneron Pharmaceuticals, Inc.
argenx SE
Alnylam Pharmaceuticals, Inc.
BeOne Medicines AG
Insmed Incorporated
Royalty Pharma plc
BioNTech SE
Roivant Sciences Ltd.
Moderna, Inc.